Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?

Creative Commons License

Akay O. M., MUTLU F., Gulbas Z.

TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.2, ss.127-130, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tjh.2014.0213
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.127-130
  • Anahtar Kelimeler: Platelet aggregation, Chronic myeloid leukemia, Imatinib mesylate, TYROSINE KINASE INHIBITOR, MYELOPROLIFERATIVE DISORDERS, C-KIT, AGGREGATION, RISTOCETIN, THROMBOSIS, MECHANISM, GROWTH, CELLS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study was to investigate the effects of imatinib mesylate on platelet aggregation and adenosine triphosphate (ATP) release in chronic myeloid leukemia patients.